Harvard Bioscience (HBIO), a global developer, manufacturer and marketer of a broad range of tools to advance life science research and regenerative medicine, announced that its wholly-owned subsidiary, Harvard Apparatus Regenerative Technology, Inc.

FORBES: Harvard Bioscience Announces Filing of IPO Registration Statement for Harvard Apparatus Regenerative Technology

In early experiments, Bhatia's lab, called the Laboratory for Multiscale Regenerative Technology, was able to infect her liver cells with malaria for the first time two weeks ago and hopes to be able to offer malaria researchers a way to test drugs that will kill the hypnozoites.

FORBES: Magazine Article

Heritage Auctions identified the buyer as Jack Wang, CEO of Biomobie, a regenerative medicine technology company located in Silicon Valley and Shanghai.

WSJ: Francis Crick's Nobel medal sells for over $2M